Dow Up 0.51% Nasdaq Up 0.24%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.64 Down 0.01(2.11%) Nov 21, 4:00PM EST
Prev Close:0.65
Open:0.65
Bid:0.57 x 500
Ask:25.00 x 15000
1y Target Est:3.50
Beta:1.78
Next Earnings Date:N/A
Day's Range:0.62 - 0.65
52wk Range:0.53 - 4.00
Volume:146,047
Avg Vol (3m):384,655
Market Cap:38.60M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 2.11%38.60M
AGENDown 1.35%183.66M
DNDN 0.00%19.69M
STMLDown 0.50%181.43M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.17
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback